Venus Remedies gets marketing authorisation for generic cancer drugs from Uzbekistan, Palestine ...Middle East

Devdiscourse - Opinion
Venus Remedies gets marketing authorisation for generic cancer drugs from Uzbekistan, Palestine
Panchkula-based pharma company Venus Remedies on Wednesday said it has received marketing authorisation for its generic cancer drugs from Uzbekistan and Palestine. The company is making big strides by extending its footprint in Central Asia and the Middle East, with the marketing approval for Carboplatin in Uzbekistan and Docetaxel and Irinotecan in Palestine, Venus Remedies said in a statement here.

Hence then, the article about venus remedies gets marketing authorisation for generic cancer drugs from uzbekistan palestine was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Venus Remedies gets marketing authorisation for generic cancer drugs from Uzbekistan, Palestine )

Apple Storegoogle play

Last updated :

Also on site :